Strategic Partnering JOINN Biologics US Inc. is a California-based contract development and manufacturing organization with a focus on biologics and advanced therapies, presenting opportunities to collaborate with pharmaceutical and biotech companies seeking scalable CDMO services from early development through clinical manufacturing.

Global Collaboration Recent high-profile partnerships in 2026 with Xbrane Biopharma AB signal a strategic emphasis on biosimilar development, suggesting a market window for prospective clients pursuing biosimilar programs and cross-border CDMO support.

Full-Service CDMO Capabilities cover from molecular developability assessments to commercial-scale cGMP manufacturing and analytical/formulation development, enabling cross-sell into clients needing end-to-end biologics development and regulatory documentation support.

Growth and Funding Past financing activity and a revenue range of 50–100 million with a multi-decade track record imply scalable capacity and investment potential for strategic customers seeking reliable manufacturing partners with financial backing.

Biologics Expertise Specialization in upstream/downstream development, cell line development, purification, and regulatory filing documentation positions JOINN as a strong partner for companies advancing complex biologics and next-generation therapies.